A case of Grover disease treated with Dupilumab: Just serendipity or a future perspective?

Dermatol Ther. 2022 May;35(5):e15429. doi: 10.1111/dth.15429. Epub 2022 Mar 22.

Authors

Francesca Barei^{1

2}, Sara Torretta^{3

4}, Nicole Morini^{1

2}, Silvia Ferrucci^{1

2}

Affiliations

¹ UOC Dermatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
² Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milan, Italy.
³ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acantholysis*
Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Ichthyosis*

Substances

Antibodies, Monoclonal, Humanized
dupilumab

Supplementary concepts

Grover's disease